Filtros de búsqueda

Lista de obras de Gerd Sutter

A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice

artículo científico publicado en 2019

A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA.

artículo científico publicado en 2005

A cellular factor is required for transcription of vaccinia viral intermediate-stage genes.

artículo científico publicado en 1994

A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).

artículo científico publicado en 2004

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM? vaccines and conventional vaccines

article

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

artículo científico publicado en 1994

A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model

artículo científico publicado en 2014

A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells

artículo científico publicado en 2017

A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens.

artículo científico publicado en 2000

A vital gene for modified vaccinia virus Ankara replication in human cells

artículo científico publicado en 2020

An anti-HIV strategy combining chemotherapy and therapeutic vaccination

artículo científico publicado en 1999

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

artículo científico publicado en 2015

Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis

artículo científico publicado en 2016

Application of light sheet microscopy for qualitative and quantitative analysis of bronchus-associated lymphoid tissue in mice

artículo científico publicado en 2018

CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection

artículo científico publicado en 2016

CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice

scholarly article by Svenja Veit et al published 16 December 2018 in Viruses

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.

artículo científico publicado en 2009

Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara

artículo científico publicado en 2014

Combating COVID-19: MVA Vector Vaccines Applied to the Respiratory Tract as Promising Approach Toward Protective Immunity in the Lung

artículo científico publicado en 2020

Comparison of the efficacy of early versus late viral proteins in vaccination against SIV

scientific article published on 01 July 2002

Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus release

artículo científico publicado en 2003

Complement component C5 recruits neutrophils in the absence of C3 during respiratory infection with modified vaccinia virus Ankara.

artículo científico publicado en 2014

Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion

artículo científico publicado en 2010

Construction and isolation of recombinant MVA.

artículo científico publicado en 2004

Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox

artículo científico publicado en 2012

Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines.

artículo científico publicado en 2007

Cross-sectional study on viraemia and shedding of porcine circovirus type 2 in a subclinically infected multiplier sow herd

artículo científico publicado en 2018

Cytosolic DNA triggers mitochondrial apoptosis via DNA damage signaling proteins independently of AIM2 and RNA polymerase III.

artículo científico publicado en 2011

Detection of a new cluster of porcine circovirus type 2b strains in domestic pigs in Germany.

artículo científico publicado en 2015

Differences between T cell epitopes recognized after immunization and after infection

artículo científico publicado en 2002

Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S

artículo científico publicado en 2018

Diverse variola virus (smallpox) strains were widespread in northern Europe in the Viking Age

scientific article published on 01 July 2020

Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara

artículo científico publicado en 2006

E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox

artículo científico publicado en 2018

Easy and efficient protocols for working with recombinant vaccinia virus MVA.

artículo científico publicado en 2012

Ectromelia virus accumulates less double-stranded RNA compared to vaccinia virus in BS-C-1 cells.

artículo científico publicado en 2017

Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease - current advances and challenges

artículo científico publicado en 2017

Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.

artículo científico publicado en 2004

Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara.

artículo científico publicado en 2001

Erratum: A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA

scholarly article published in Nature Immunology

Evaluation in Rhesus Macaques of Tat and Rev-Targeted Immunization as a Preventive Vaccine against Mucosal Challenge with SHIV-BX08

artículo científico publicado en 2002

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model

artículo científico publicado en 2010

Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.

artículo científico publicado en 2007

Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.

artículo científico publicado en 2008

Full genome characterization of porcine circovirus type 3 isolates reveals the existence of two distinct groups of virus strains

artículo científico publicado en 2018

Full-length core sequence dependent complex-type glycosylation of hepatitis C virus E2 glycoprotein.

artículo científico publicado en 2002

Functional Evaluation of HIV/SIV Nef as Superantigen

article

Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells

artículo científico publicado en 2010

Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma

artículo científico publicado en 2003

Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts

artículo científico publicado en 2009

Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors.

artículo científico publicado en 1998

Generation of recombinant fowlpox virus using the non-essential F11L orthologue as insertion site and a rapid transient selection strategy

artículo científico publicado en 2002

Generation of therapeutic antisera for emerging viral infections

artículo científico publicado en 2018

HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway.

artículo científico publicado en 2004

Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells

artículo científico publicado en 1998

Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates

artículo científico publicado en 1996

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice

artículo científico publicado en 2003

Human tumor growth is inhibited by a vaccinia virus carrying the E2 gene of bovine papillomavirus

artículo científico publicado en 2000

Humoral and cellular immune responses to HIV-1 Nef in mice DNA-immunised with non-replicating or self-replicating expression vectors

article

IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs

artículo científico

IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice

artículo científico publicado en 2003

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

artículo científico publicado en 2002

Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway.

artículo científico publicado en 2001

Immunization of Patients with Malignant Melanoma with Autologous CD34+ Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I Trial

article

Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f

article

Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques.

artículo científico publicado en 2002

Immunogenic cell death of dendritic cells following modified vaccinia virus Ankara infection enhances CD8 T cell proliferation

artículo científico publicado en 2018

Immunogenicity and protective efficacy of recombinant Modified Vaccinia virus Ankara candidate vaccines delivering West Nile virus envelope antigens

artículo científico publicado en 2016

Improved host range selection for recombinant modified vaccinia virus Ankara

artículo científico publicado en 2003

In situ amplification of measles virus RNA by the self-sustained sequence replication reaction.

artículo científico publicado en 1995

In vivo attenuation of recombinant murine gammaherpesvirus 68 (MHV-68) is due to the expression and immunogenicity but not to the insertion of foreign sequences

artículo científico publicado en 2008

Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara

artículo científico publicado en 2005

Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice

artículo científico publicado en 2016

Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells.

artículo científico publicado en 2009

Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial

article

Induction of Noxa-mediated apoptosis by modified vaccinia virus Ankara depends on viral recognition by cytosolic helicases, leading to IRF-3/IFN-β-dependent induction of pro-apoptotic Noxa.

artículo científico publicado en 2011

Induction of influenza (H5N8) antibodies by modified vaccinia virus Ankara H5N1 vaccine

artículo científico publicado en 2015

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity

artículo científico publicado en 2001

Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity

artículo científico publicado en 2006

Interleukin-1β receptor expressed by modified vaccinia virus Ankara interferes with interleukin-1β activity produced in various virus-infected antigen-presenting cells

artículo científico publicado en 2013

In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity

artículo científico publicado en 2016

Live viral vectors: vaccinia virus

artículo científico publicado en 2003

Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.

artículo científico publicado en 2016

Low prevalence of porcine circovirus type 2 infections in farrowing sows and corresponding pre-suckling piglets in southern German pig farms

artículo científico publicado en 2016

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

artículo científico publicado en 2009

Manifold Roles of CCR7 and Its Ligands in the Induction and Maintenance of Bronchus-Associated Lymphoid Tissue.

artículo científico publicado en 2018

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

artículo científico publicado en 1991

Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection

artículo científico publicado en 2008

Melanoma patients respond to a new HLA-A*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2.

artículo científico publicado en 2005

Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro

artículo científico publicado en 2004

Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies

artículo científico publicado en 2013

Modified Vaccinia Virus Ankara

artículo científico publicado en 2017

Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.

artículo científico publicado en 2017

Modified Vaccinia virus Ankara but not vaccinia virus induces chemokine expression in cells of the monocyte/macrophage lineage.

artículo científico publicado en 2015

Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling

artículo científico

Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

artículo científico publicado en 2004

Modified vaccinia virus Ankara delivers a robust surrogate marker for immune monitoring to sarcoma cells even if cells are being exposed to chemotherapy and heat treatment

artículo científico publicado en 2012

Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo

artículo científico publicado en 1999

Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses

artículo científico publicado en 2007

Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis

artículo científico publicado en 2006

Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases

artículo científico publicado en 2014

Modified vaccinia virus ankara (MVA)--development as recombinant vaccine and prospects for use in veterinary medicine

artículo científico publicado en 2015

Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression

artículo científico publicado en 2009

Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.

artículo científico publicado en 2003

Myristoylation increases the CD8+T-cell response to a GFP prototype antigen delivered by modified vaccinia virus Ankara

artículo científico publicado en 2016

Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins

artículo científico publicado en 2002

N-terminal domain of Schmallenberg virus envelope protein Gc delivered by recombinant equine herpesvirus type 1 and modified vaccinia virus Ankara: Immunogenicity and protective efficacy in cattle

artículo científico publicado en 2018

N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection

artículo científico publicado en 2011

Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.

artículo científico publicado en 2004

Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes

artículo científico publicado en 2016

Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase

scientific article published on 01 August 1995

Nonreplicating vaccinia vector efficiently expresses recombinant genes ⬇️

artículo científico publicado el 15 de noviembre de 1992

Novel vaccine delivery systems: solutions to HIV vaccine dilemmas?

artículo científico publicado en 2001

Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus

artículo científico publicado en 1995

Obstetric Ultrasonography to Detect Fetal Abnormalities in a Mouse Model for Zika Virus Infection

scientific article published on 07 January 2020

Occurrence of genotypes of porcine circovirus (PCV2) in pig farms using different vaccination strategies against PCV2

artículo científico publicado en 2017

Partial tyrosinase-specific self tolerance by HLA-A*0201-restricted cytotoxic T lymphocytes in mice and man

artículo científico publicado en 2004

Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.

artículo científico publicado en 1996

Pharmacokinetics and Safety of Macrocyclic Gadobutrol in Children Aged Younger Than 2 Years Including Term Newborns in Comparison to Older Populations

artículo científico publicado en 2015

Piscine Orthoreovirus 3 Is Not the Causative Pathogen of Proliferative Darkening Syndrome (PDS) of Brown Trout ()

artículo científico publicado en 2019

Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox

artículo científico publicado en 2009

Poxvirus vectors

artículo científico publicado en 2013

Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses.

artículo científico publicado en 2009

Proliferative Kidney Disease and Proliferative Darkening Syndrome are Linked with Brown Trout (Salmo trutta fario) Mortalities in the Pre-Alpine Isar River

artículo científico publicado en 2019

Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells

artículo científico publicado en 2005

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

artículo científico publicado en 2015

Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins.

artículo científico publicado en 2004

Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies

artículo científico

Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions

artículo científico publicado en 2008

Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model

artículo científico publicado en 2008

Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.

artículo científico

Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara

artículo científico publicado en 2014

Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes.

artículo científico publicado en 1997

Recombinant Vaccinia Virus MVA for Generation and Analysis of T Cell Responses Against Tumor Associated Antigens

artículo científico publicado en 2000

Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge

artículo científico publicado en 2014

Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

artículo científico publicado en 2009

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

artículo científico publicado en 2007

Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model

artículo científico publicado en 2007

Recombinant viruses delivering the necroptosis mediator MLKL induce a potent antitumor immunity in mice

scientific article published on 20 August 2020

Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.

artículo científico publicado en 2003

Rescue of measles virus using a replication-deficient vaccinia-T7 vector

artículo científico publicado en 1997

Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes

artículo científico publicado en 2005

Rusa alfredi papillomavirus 1 - a novel deltapapillomavirus inducing endemic papillomatosis in the endangered Visayan spotted deer.

artículo científico publicado en 2015

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

scientific article published on 20 April 2020

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial.

artículo científico publicado en 2014

Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection

artículo científico publicado en 2020

Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus.

artículo científico publicado en 1998

Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus Ankara

artículo científico publicado en 2006

Smallpox vaccines: New formulations and revised strategies for vaccination.

artículo científico publicado en 2009

Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytes

artículo científico publicado en 1999

Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.

artículo científico publicado en 1994

Sus scrofa papillomavirus 2 - genetic characterization of a novel suid papillomavirus from wild boar in Germany.

artículo científico publicado en 2017

T cell responses to respiratory syncytial virus fusion and attachment proteins in human peripheral blood mononuclear cells

artículo científico publicado en 2006

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates.

artículo científico publicado en 2016

Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication

artículo científico publicado en 2002

The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex

artículo científico publicado en 2008

The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in nonpermissive human and murine cells.

artículo científico publicado en 2009

The poxviral scrapin MV-LAP requires a myxoma viral infection context to efficiently downregulate MHC-I molecules

artículo científico publicado en 2005

Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy

artículo científico publicado en 2007

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals

article

Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise

scientific article published on 12 August 2020

Tracking Modified Vaccinia Virus Ankara in the Chicken Embryo: In Vivo Tropism and Pathogenesis of Egg Infections

scientific article published on 24 August 2018

Transient host range selection for genetic engineering of modified vaccinia virus Ankara

artículo científico publicado en 2000

Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope

artículo científico publicado en 2000

Transporter (TAP)‐ and proteasome‐independent presentation of a melanoma‐associated tyrosinase epitope

Type I interferon receptor signaling delays Kupffer cell replenishment during acute fulminant viral hepatitis

artículo científico publicado en 2017

Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.

artículo científico publicado en 2010

Uptake of antigens from modified vaccinia Ankara virus-infected leukocytes enhances the immunostimulatory capacity of dendritic cells.

artículo científico publicado en 2011

Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky

artículo científico publicado en 2015

Vaccination with Rev and Tat against AIDS.

artículo científico publicado en 1999

Vaccination with a Modified Vaccinia Virus Ankara-based vaccine protects mice from allergic sensitization

artículo científico publicado en 2008

Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge

artículo científico publicado en 2007

Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice

artículo científico publicado en 2013

Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice.

artículo científico publicado en 2013

Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model

artículo científico publicado en 2001

Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens.

artículo científico publicado en 2004

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity

artículo científico publicado en 2007

Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery

artículo científico publicado en 2003

Vaccinia virus double-stranded RNA-binding protein E3 does not interfere with siRNA-mediated gene silencing in mammalian cells.

artículo científico

Vaccinia virus replication is not affected by APOBEC3 family members

artículo científico publicado en 2006

Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components

artículo científico publicado en 2008

Vesicular stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies

artículo científico publicado en 2007

Viral host-range factor C7 or K1 is essential for modified vaccinia virus Ankara late gene expression in human and murine cells, irrespective of their capacity to inhibit protein kinase R-mediated phosphorylation of eukaryotic translation initiation

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda